Christopher M Rath

Christopher M Rath is an accomplished research scientist with extensive experience in analytical development and process analytics, currently serving as Principal Research Scientist II and Process Analytics Lead at AbbVie since January 2024. Previously, Christopher held key leadership roles, including Director of Platform Screening at Totus Medicines, where a novel drug screening pipeline was developed, and Director of Screening and Analytics at Sestina Bio, which focused on innovative solutions in synthetic biology. Christopher's expertise spans various organizations, including Ometa Labs, AbSci, and Novartis, where advanced technologies like mass spectrometry and high-throughput assays were utilized to facilitate drug development. Academic credentials include a PhD in Chemical Biology from the University of Michigan and a BS in Biochemistry and Molecular Biology from the University of California at Santa Cruz.